Table 1.

Drug combinations tested in the current study.

Optimal_A	Optimal_AA	Optimal_B	Subpot_A	Subpot_B
IFN-β	IFN-α	RIB	IFN-α	IFN-α
3.1 ng/mL	3.1 ng/mL	25,000 ng/mL	0.8 ng/mL	0.8 ng/mL
IFN-γ	IFN-γ	IFN-β	IFN-β	IFN-β
3.1 ng/mL	3.1 ng/mL	0.2 ng/mL	0.8 ng/mL	0.8 ng/mL
ACV	ACV	ACV	IFN-γ	IFN-γ
80 ng/mL	80 ng/mL	80 ng/mL	0.8 ng/mL	0.8 ng/mL
			ACV	RIB
			20 ng/mL	390 ng/mL